Hussman Strategic Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,000
Closed -$1.95M 232
2026
Q1
$1.95M Buy
+21,000
New +$1.86M 0.42% 107
2024
Q3
Sell
-10,500
Closed -$1.49M 221
2024
Q2
$1.49M Hold
10,500
0.41% 105
2024
Q1
$1.17M Hold
10,500
0.27% 136
2023
Q4
$1.36M Buy
10,500
+4,200
+67% +$579K 0.31% 133
2023
Q3
$1.03M Buy
6,300
+3,200
+103% +$563K 0.2% 192
2023
Q2
$568K Sell
3,100
-15,500
-83% -$2.23M 0.1% 245
2023
Q1
$2.48M Sell
18,600
-27,900
-60% -$3.28M 0.39% 101
2022
Q4
$3.69M Hold
46,500
0.6% 48
2022
Q3
$2.82M Buy
46,500
+10,100
+28% +$652K 0.49% 69
2022
Q2
$2M Buy
+36,400
New +$2.11M 0.34% 103
2018
Q2
Sell
-50,000
Closed -$1.23M 220
2018
Q1
$1.23M Buy
+50,000
New +$1.31M 0.34% 113

Other funds holding ACLS

Hussman Strategic Advisors's ACLS Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 21,000 shares — an estimated $1.95M sold.

Hussman Strategic Advisors first reported a position in ACLS in Q1 2018 and held it in 11 quarters. The position peaked at $3.69M in Q4 2022. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Hussman Strategic Advisors reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 21,000 Axcelis shares in Q2 2026, an estimated $1.95M.
  • Hussman Strategic Advisors first reported a position in Axcelis in Q1 2018 and held it in 11 quarters.
  • Hussman Strategic Advisors's Axcelis position peaked at $3.69M in Q4 2022.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.